3 weeks BMRN vs. INCY: Which Stock Is the Better Value Option?Zacks

BMRN vs. INCY: Which Stock Is the Better Value Option?

Biomarin Pharma (BMRN) · Incyte (INCY)

22 hours Goldman Sachs: Incyte Corporation (INCY) Is A Top Growth Investor StockInsider Monkey X

1 day Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

2 days Biomarin: Challanges Mount, But Sale Rumours Make For A Risky “Buy” CallSeeking Alpha X

2 days Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreZacks X

2 days Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Value StockZacks X

3 days Here’s Why BioMarin Pharmaceutical (BMRN) is a Strong Growth StockZacks X

4 days Incyte Pauses Enrollment in Chronic Spontaneous Urticaria StudyZacks X

4 days Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.Investor's Business Daily X

4 days After-hours movers: Super Micro Computer, Bakkt Holdings, Incyte, and moreInvesting.com X

5 days Is Incyt Corporation (INCY) the Best Immunotherapy Stock to Buy Now?Insider Monkey X

2 weeks Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)Insider Monkey X

3 weeks Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think “Yes”Zacks X

3 weeks BioMarin (BMRN) Upgraded to Buy: Here’s WhyZacks X

3 weeks Incyte (NASDAQ:INCY) Announces Quarterly Earnings ResultsMarketBeat X

3 weeks Earnings call: BioMarin reports robust Q3 growth with VOXZOGO sales surgeInvesting.com X

3 weeks Earnings call: Incyte reports robust growth and pipeline progressInvesting.com X

3 weeks Royal Bank of Canada Reiterates “Sector Perform” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)MarketBeat X

3 weeks BioMarin Q3 Earnings & Revenues Beat Estimates, ’24 Guidance RaisedZacks X

3 weeks BioMarin Pharmaceutical Inc. (BMRN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

3 weeks BioMarin (BMRN) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks X

4 weeks Incyte (NASDAQ:INCY) Raised to “Buy” at Bank of AmericaMarketBeat X

4 weeks Incyte Breaks Out To 17-Month High As Jakafi Demand SurgesInvestor's Business Daily X

4 weeks INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product SalesZacks X

4 weeks Here’s What Key Metrics Tell Us About Incyte (INCY) Q3 EarningsZacks X

4 weeks Incyte Co. (NASDAQ:INCY) Shares Sold by Mediolanum International Funds LtdMarketBeat X

4 weeks Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY)MarketBeat X

1 month Incyte Gears Up to Report Q3 Earnings: Here’s What You Should KnowZacks X

1 month BioMarin Pharmaceutical (BMRN) to Release Quarterly Earnings on TuesdayMarketBeat X

1 month Incyte (INCY) Scheduled to Post Quarterly Earnings on TuesdayMarketBeat X